828 related articles for article (PubMed ID: 19781428)
21. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population.
Lappé JM; Horne BD; Shah SH; May HT; Muhlestein JB; Lappé DL; Kfoury AG; Carlquist JF; Budge D; Alharethi R; Bair TL; Kraus WE; Anderson JL
Clin Chim Acta; 2011 Nov; 412(23-24):2094-9. PubMed ID: 21821014
[TBL] [Abstract][Full Text] [Related]
22. Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure.
Makhoul BF; Khourieh A; Kaplan M; Bahouth F; Aronson D; Azzam ZS
Int J Cardiol; 2013 Aug; 167(4):1412-6. PubMed ID: 22560496
[TBL] [Abstract][Full Text] [Related]
23. Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction.
Kim J; Kim YD; Song TJ; Park JH; Lee HS; Nam CM; Nam HS; Heo JH
Thromb Haemost; 2012 Aug; 108(2):349-56. PubMed ID: 22739700
[TBL] [Abstract][Full Text] [Related]
24. Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease.
Tonelli M; Sacks F; Arnold M; Moye L; Davis B; Pfeffer M;
Circulation; 2008 Jan; 117(2):163-168. PubMed ID: 18172029
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism.
Zorlu A; Bektasoglu G; Guven FM; Dogan OT; Gucuk E; Ege MR; Altay H; Cinar Z; Tandogan I; Yilmaz MB
Am J Cardiol; 2012 Jan; 109(1):128-34. PubMed ID: 21958741
[TBL] [Abstract][Full Text] [Related]
26. Inflammation, as measured by the erythrocyte sedimentation rate, is an independent predictor for the development of heart failure.
Ingelsson E; Arnlöv J; Sundström J; Lind L
J Am Coll Cardiol; 2005 Jun; 45(11):1802-6. PubMed ID: 15936609
[TBL] [Abstract][Full Text] [Related]
27. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Nov; 38(9):2895-8. PubMed ID: 17112858
[TBL] [Abstract][Full Text] [Related]
28. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
[TBL] [Abstract][Full Text] [Related]
29. Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Askevold ET; Nymo S; Ueland T; Gravning J; Wergeland R; Kjekshus J; Yndestad A; Cleland JG; McMurray JJ; Aukrust P; Gullestad L
Circ Heart Fail; 2013 Jan; 6(1):91-8. PubMed ID: 23230311
[TBL] [Abstract][Full Text] [Related]
30. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
[TBL] [Abstract][Full Text] [Related]
31. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure.
Allen LA; Felker GM; Mehra MR; Chiong JR; Dunlap SH; Ghali JK; Lenihan DJ; Oren RM; Wagoner LE; Schwartz TA; Adams KF
J Card Fail; 2010 Mar; 16(3):230-8. PubMed ID: 20206898
[TBL] [Abstract][Full Text] [Related]
32. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
[TBL] [Abstract][Full Text] [Related]
33. Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
Wagner M; Alam A; Zimmermann J; Rauh K; Koljaja-Batzner A; Raff U; Wanner C; Schramm L
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1573-9. PubMed ID: 21734083
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients.
Ueland T; Kjekshus J; Frøland SS; Omland T; Squire IB; Gullestad L; Dickstein K; Aukrust P
J Am Coll Cardiol; 2005 Dec; 46(11):2018-21. PubMed ID: 16325035
[TBL] [Abstract][Full Text] [Related]
35. [Impact of red cell distribution width on outcome of 16 681 patients with chronic systolic heart failure].
Yu SB; Cui HY; Qin M; Liu T; Kong B; Zhao QY; Huang H; Huang CX
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):237-42. PubMed ID: 22801270
[TBL] [Abstract][Full Text] [Related]
36. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study.
Panichi V; Rosati A; Bigazzi R; Paoletti S; Mantuano E; Beati S; Marchetti V; Bernabini G; Grazi G; Rizza GM; Migliori M; Giusti R; Lippi A; Casani A; Barsotti G; Tetta C;
Nephrol Dial Transplant; 2011 Aug; 26(8):2641-8. PubMed ID: 21325348
[TBL] [Abstract][Full Text] [Related]
37. Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.
Sola S; Mir MQ; Rajagopalan S; Helmy T; Tandon N; Khan BV
J Card Fail; 2005 Oct; 11(8):607-12. PubMed ID: 16230264
[TBL] [Abstract][Full Text] [Related]
38. Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure.
Kavsak PA; MacRae AR; Newman AM; Lustig V; Palomaki GE; Ko DT; Tu JV; Jaffe AS
Clin Biochem; 2007 Mar; 40(5-6):326-9. PubMed ID: 17292342
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein in chronic heart failure: a new predictor of survival.
Celik T; Iyisoy A; Celik M; Yuksel UC; Kardesoglu E
Int J Cardiol; 2009 Jul; 135(3):396-7. PubMed ID: 18501446
[TBL] [Abstract][Full Text] [Related]
40. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
QJM; 2008 May; 101(5):397-405. PubMed ID: 18292098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
